Concepedia

Holly Morris

HM

6

Publications

1K

Citations

6

H-Index

1978

Active since

Affiliations

Transgenomic (United States)(Current)

Frederick National Laboratory for Cancer Research

Cancer Genetics (United States)

Leidos (United States)

National Institutes of Health

Holly Morris is an author at Transgenomic (United States) specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

1978–2018

6

Publications

6

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature

Steven Seaman, Zhongyu Zhu, Saurabh Saha et al. · Cancer Cell · 2017 · 427 citations

, , +10

COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models

Lihong Xu, Janine Stevens, Mary Beth Hilton et al. · Science Translational Medicine · 2014 · 217 citations · Full text

GPR124 Functions as a WNT7-Specific Coactivator of Canonical β-Catenin Signaling

Ekaterina Posokhova, Animesh Shukla, Steven Seaman et al. · Cell Reports · 2014 · 151 citations · Full text

Tumor stroma–targeted antibody-drug conjugate triggers localized anticancer drug release

Christopher Szot, Saurabh Saha, Xiaoyan M. Zhang et al. · Journal of Clinical Investigation · 2018 · 118 citations · Full text

, , +14

Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia.

D M Jenkins, J. A. Need, James S. Scott et al. · BMJ · 1978 · 74 citations · Full text

, , +14

Rows per page

1–5 of 6